Cite
HARVARD Citation
Sama, I. et al. (2020). New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease. European heart journal. pp. 4047-4049. [Online].